.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Esophageal squamous cell carcinoma (ESCC) remains a formidable challenge due to its aggressive nature and limited therapeutic options. Recent research has identified a significant driver of this malignancy: the novel protein circVEGFC-182aa in ESCC. This 182-amino acid secretory protein, which circular RNA encodes, plays a pivotal role in remodeling the tumor microenvironment. Therefore, understanding this mechanism is crucial for developing better clinical strategies.
Scientists found that circVEGFC is significantly more abundant in ESCC tissues than in healthy samples. Consequently, patients with high expression levels often face advanced tumor stages and lower survival rates. The research team used mass spectrometry and Western blotting to identify the protein in cell supernatants. Because the protein is secretory, it can travel through the microenvironment to influence neighboring immune cells.
The protein interacts directly with tumor-associated macrophages. Specifically, it binds to transforming growth factor-beta receptor II (TGF-βRII) on the macrophage surface. This binding activates the Smad2/3 signaling pathway, which forces the macrophages to adopt an M2-polarized phenotype. These M2 macrophages then actively support tumor progression instead of fighting the malignancy.
This cellular shift promotes several malignant behaviors, including increased cell migration and invasion. In addition, the study showed that circVEGFC-182aa triggers the epithelial-mesenchymal transition in ESCC cells. Furthermore, mouse models confirmed that the protein significantly accelerates lung metastasis and overall tumor growth. However, researchers noted that inhibiting the TGF-β signaling pathway could successfully halt these aggressive processes.
This protein is unique because a circular RNA (circRNA) encodes it, a process previously thought to be rare. Its secretory nature allows it to remodel the immune microenvironment directly. This makes it a powerful driver of cancer progression and a potential prognostic biomarker for clinicians.
The protein induces M2 polarization in macrophages through the TGF-β pathway. These specialized immune cells then release factors that enhance ESCC cell invasion and trigger the epithelial-mesenchymal transition. This mechanism leads to increased spread to distant organs, such as the lungs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Wang Y et al. A novel secretory protein, circVEGFC-182aa, promotes esophageal squamous cell carcinoma progression by inducing M2 polarization of tumor-associated macrophages via regulating the TGF-β pathway. J Transl Med. 2026 May 29. doi: 10.1186/s12967-026-08362-0. PMID: 42216222.
Li Y et al. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma. EBioMedicine. 2021;70:103510. doi: 10.1016/j.ebiom.2021.103510.
Chu LY et al. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol. 2020;26(15):1708-1725. doi: 10.3748/wjg.v26.i15.1708.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research identifies circVEGFC-182aa as a novel secretory protein that promotes ESCC progression by inducing M2 macrophage polarization via TGF-β signaling....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
